目錄:MedChemExpress LLC>>生化試劑>> VAS2870 | MCE
CAS | 722456-31-7 | 純度 | 98.45% |
---|---|---|---|
分子量 | 360.39 | 分子式 | C??H??N?OS |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5 mg |
貨號 | HY-12804 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥/生物制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù),。
CAS No. : 722456-31-7
產(chǎn)品活性:VAS2870 is a NADPH oxidase (NOX) inhibitor.
研究領(lǐng)域:Metabolic Enzyme/Protease
作用靶點:NADPH Oxidase
In Vitro: VAS2870 is effective to suppress PDGF-BB-dependent activation of NADPH oxidase and subsequent production of intracellular ROS. Furthermore, VAS2870 suppresses PDGF-BB-dependent chemotaxis, but not DNA synthesis. Preincubation with VAS2870 (10 and 20 μM) completely abolishes PDGF-mediated NADPH oxidase activation and ROS production. Preincubation with VAS2870 (0.1-20 μM) does not affect PDGF-induced cell cycle progression. However, it abolishes PDGF-dependent chemotaxis of VSMC in a concentration-dependent manner (100% inhibition at 10 μM). VAS2870 inhibits dose-dependently autocrine increase of cell number in FaO rat hepatoma cells, and almost completely blocked ROS production and thymidine incorporation when used at 25 mM. VAS2870 blocks serum-dependent cell growth of FaO rat hepatoma cells. VAS2870 inhibits proliferation of different human hepatocellular carcinoma (HCC) cell lines. VAS2870 pretreatment enhances TGF-b-mediated apoptosis of FaO rat hepatoma cells.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | Anti-Aging Compound Library | Antioxidant Compound Library | Oxygen Sensing Compound Library | Anti-Cardiovascular Disease Compound Library | Ferroptosis Compound Library | Glutamine Metabolism Compound Library | Anti-Cancer Metabolism Compound Library | Glucose Metabolism Compound Library | Targeted Diversity Library | Human Metabolite Library | Anti-Pulmonary Fibrosis Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | ML171 | GLX351322 | Diphenyleneiodonium chloride | APX-115 free base | VAS 3947 | Mulberrofuran G | Fluoflavine | GSK2795039 | Setanaxib | NADPH oxidase-IN-1 | GKT136901 | Fulvene-5 | NoxA1ds | (Rac)-Nebivolol
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑,、激動劑涉及各熱門信號通路及疾病領(lǐng),;
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,,常用試劑盒 ,,更有 PROTAC、ADC 等特色產(chǎn)品,,廣泛應(yīng)用于新藥研發(fā),、生命科學(xué)等科研項目;
• 提供虛擬篩選,,離子通道篩選,,代謝組學(xué)分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù),;
• 設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控,、驗證體系;
• 提供 LC/MS,、NMR,、HPLC、手性分析,、元素分析等各項質(zhì)檢報告,,確保產(chǎn)品的高純度、高品質(zhì),;
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證,;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果,;
• 專業(yè)團隊跟蹤新的制藥及生命科學(xué)研究進展,為您提供*新的活性化合物,;
• 與世界各大制藥公司及*科研機構(gòu)建立了長期的合作。
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)